Geographical representation of low-and middle-income countries in randomized clinical trials for COVID-19
Geographical Representation of Low- and Middle-Income Countries in Randomized Clinical
Trials for COVID-19 | Infectious Diseases | JAMA Network Open | JAMA Network [Skip to …
Trials for COVID-19 | Infectious Diseases | JAMA Network Open | JAMA Network [Skip to …
[HTML][HTML] A living mapping review for COVID-19 funded research projects: one year update
A Norton, A Bucher, E Antonio… - Wellcome Open …, 2022 - wellcomeopenresearch.org
Background: The coronavirus disease 2019 (COVID-19) has resulted in an unprecedented
research response, demonstrating exceptional examples of rapid research and …
research response, demonstrating exceptional examples of rapid research and …
[HTML][HTML] Leadership and international collaboration on COVID-19 research: reducing the North–South divide?
The COVID-19 pandemic triggered unprecedented scientific efforts worldwide and launched
several initiatives to promote international cooperation. Because international scientific …
several initiatives to promote international cooperation. Because international scientific …
[HTML][HTML] Clinical trials and their impact on policy during COVID-19: a review
Background Of over 8,000 recorded randomised trials addressing COVID-19, around 80%
were of treatments, and 17% have reported results. Approximately 1% were adaptive or …
were of treatments, and 17% have reported results. Approximately 1% were adaptive or …
Inequity and disparities mar existing global research evidence on Long COVID
MH Taghrir, H Akbarialiabad… - Global Health …, 2023 - journals.sagepub.com
Since the pandemic began in December 2019, SARS-Cov2 has accentuated the wide gap
and disparities in socioeconomic and healthcare access at individual, community, country …
and disparities in socioeconomic and healthcare access at individual, community, country …
Reduced mortality among COVID-19 ICU patients after treatment with HemoClear convalescent plasma in Suriname
R Bihariesingh-Sanchit, R Bansie, N Ramdhani… - MBio, 2023 - Am Soc Microbiol
Convalescent plasma is a promising therapy for coronavirus disease 2019 (COVID-19), but
its efficacy in intensive care unit (ICU) patients in low-and middle-income country settings …
its efficacy in intensive care unit (ICU) patients in low-and middle-income country settings …
[HTML][HTML] A living mapping review for COVID-19 funded research projects: final (27 month) update
A Bucher, E Antonio, N Jabin, C Jones… - Wellcome Open …, 2020 - ncbi.nlm.nih.gov
Background: The coronavirus disease 2019 (COVID-19) has resulted in an unprecedented
research response, demonstrating exceptional examples of rapid research and …
research response, demonstrating exceptional examples of rapid research and …
Improving coherence of global research funding: Pandemic PACT
A Norton, L Sigfrid, E Antonio… - Lancet (London …, 2024 - pubmed.ncbi.nlm.nih.gov
Improving coherence of global research funding: Pandemic PACT Improving coherence of
global research funding: Pandemic PACT Lancet. 2024 Mar 30;403(10433):1233. doi …
global research funding: Pandemic PACT Lancet. 2024 Mar 30;403(10433):1233. doi …
[HTML][HTML] Combined effect of traditional Chinese herbal-based formulations Jing Si herbal tea and Jing Si nasal drop inhibits adhesion and transmission of SARS-CoV2 …
Multiple studies show increased severity of SARS-CoV2-infection in patients with
comorbidities such as hypertension and diabetes. In this study, we have prepared two …
comorbidities such as hypertension and diabetes. In this study, we have prepared two …